期刊
AGING CELL
卷 20, 期 12, 页码 -出版社
WILEY
DOI: 10.1111/acel.13506
关键词
aging; Cre-Lox; growth hormone; IGF-1; insulin sensitivity; lifespan; tamoxifen
资金
- NIH [AG13319, R01AG059779]
Studies suggest that reducing growth hormone action can enhance healthy lifespan. In adult mice, disrupted GH action resulted in sexual dimorphic effects, with males showing enhanced insulin sensitivity and reduced tumors, while females exhibited increased lifespan and reduced glucose and oxidative stress.
Studies in multiple species indicate that reducing growth hormone (GH) action enhances healthy lifespan. In fact, GH receptor knockout (GHRKO) mice hold the Methuselah prize for the world's longest-lived laboratory mouse. We previously demonstrated that GHR ablation starting at puberty (1.5 months), improved insulin sensitivity and female lifespan but results in markedly reduced body size. In this study, we investigated the effects of GHR disruption in mature-adult mice at 6 months old (6mGHRKO). These mice exhibited GH resistance (reduced IGF-1 and elevated GH serum levels), increased body adiposity, reduced lean mass, and minimal effects on body length. Importantly, 6mGHRKO males have enhanced insulin sensitivity and reduced neoplasms while females exhibited increased median and maximal lifespan. Furthermore, fasting glucose and oxidative damage was reduced in females compared to males irrespective of Ghr deletion. Overall, disrupted GH action in adult mice resulted in sexual dimorphic effects suggesting that GH reduction at older ages may have gerotherapeutic effects.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据